» Articles » PMID: 35145658

Total Mesorectal Excision Laparoscopic Versus Transanal Approach for Rectal Cancer: A Systematic Review and Meta-analysis

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2022 Feb 11
PMID 35145658
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Total mesorectal excision (TME) performed for the first time by Held through an open approach, it has become the standard technique for the surgical treatment of rectal cancer. The aim the of this meta-analysis is to compare the outcomes provided by TaTME than LaTME.

Material And Methods: In this meta-analysis, we included all comparative studies, prospective and retrospective, which addressed in low and middle rectal cancer, a comparison between TaTME and LaTME. A search was performed through MEDLINE and Cochrane Database. 846 records were identified.

Results: Eight relevant studies have been included in this meta-analysis. The studies were from France, Russia, USA, Netherlands, Taiwan, Egypt. The eight studies including 471 patients with middle or low rectal cancer.

Conclusion: The meta-analysis confirmed safety of TaTME for low and middle rectal cancer. TaTME can lead to a high quality of rectal cancer resection specimen.

Citing Articles

Comparative efficacy analysis of laparoscopic-assisted transanal total mesorectal excision laparoscopic transanal mesorectal excision for low-lying rectal cancer.

Lu F, Tan S, Zuo J, Jiang H, Wang J, Jiang Y World J Gastrointest Surg. 2025; 17(1):100364.

PMID: 39872764 PMC: 11757205. DOI: 10.4240/wjgs.v17.i1.100364.


Three-Year Analysis of the Rectal Cancer Care Trajectory after the COVID-19 Pandemic.

Braicu V, Fulger L, Nelluri A, Maganti R, Shetty U, Verdes G Diseases. 2023; 11(4).

PMID: 38131987 PMC: 10742543. DOI: 10.3390/diseases11040181.


The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis.

Tejedor P, Arredondo J, Simo V, Zorrilla J, Baixauli J, Jimenez L Updates Surg. 2023; 75(8):2191-2200.

PMID: 37903996 DOI: 10.1007/s13304-023-01676-4.


A short-term study of laparoscopic-dominant individualised levator ani resection in abdominoperineal resection: A retrospective investigation.

Xue X, Jian C, Fang Y, Luo L, Guo Y, Ling B J Minim Access Surg. 2023; 20(1):55-61.

PMID: 37706404 PMC: 10898643. DOI: 10.4103/jmas.jmas_168_22.


Simple transanal total mesorectal resection versus laparoscopic transabdominal total mesorectal resection for the treatment of low rectal cancer: a single-center retrospective case-control study.

Yang W, Chen W, He Z, Wu Z, Liu H, Li G Front Surg. 2023; 10:1171382.

PMID: 37576920 PMC: 10413134. DOI: 10.3389/fsurg.2023.1171382.


References
1.
Velthuis S, Nieuwenhuis D, Ruijter T, Cuesta M, Bonjer H, Sietses C . Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc. 2014; 28(12):3494-9. DOI: 10.1007/s00464-014-3636-1. View

2.
Rasulov A, Mamedli Z, Gordeyev S, Kozlov N, Dzhumabaev H . Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol. 2016; 20(4):227-34. DOI: 10.1007/s10151-015-1421-3. View

3.
Lelong B, Meillat H, Zemmour C, Poizat F, Ewald J, Mege D . Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study. J Am Coll Surg. 2016; 224(5):917-925. DOI: 10.1016/j.jamcollsurg.2016.12.019. View

4.
Marks J, Montenegro G, Salem J, Shields M, Marks G . Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol. 2016; 20(7):467-73. DOI: 10.1007/s10151-016-1482-y. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View